Herein the anti-influenza drug (–)-oseltamivir phosphate is prepared in continuous
flow from ethyl shikimate with 54% overall yield over nine steps and total residence
time of 3.5 min from the individual steps. Although the procedure involved intermediate
isolation, the dangerous azide chemistry and intermediates involved were elegantly
handled in situ. It is the first continuous-flow process for (–)-oseltamivir phosphate involving
azide chemistry and (–)-shikimic acid as precursor.
Key words
azide chemistry - continuous flow - influenza - (–)-oseltamivir phosphate - total
synthesis